[1]陈圳炜 曾海鸥 罗敏虹 袁丽萍 马红梅 伍强 李强翔 杨铁城*.糖尿病肾病与非糖尿肾病维持性血液透析患者桡动脉钙化情况及危险因素分析[J].内科,2015,(05):601-603+642.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2015.05.02]
 CHEN Zhen-wei,ZENG Hai-ou,LUO Min-hong,et al.Radial artery calcification and its risk factors in maintenance hemodialysis patients with and without diabetic nephropathy[J].Internal Medicine of China,2015,(05):601-603+642.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2015.05.02]
点击复制

糖尿病肾病与非糖尿肾病维持性血液透析患者桡动脉钙化情况及危险因素分析()
分享到:

《内科》[ISSN:1006-6977/CN:61-1281/TN]

卷:
期数:
2015年05期
页码:
601-603+642
栏目:
论著
出版日期:
2015-10-15

文章信息/Info

Title:
Radial artery calcification and its risk factors in maintenance hemodialysis patients with and without diabetic nephropathy
文章编号:
1673-7768(2015)05-0601-04
作者:
陈圳炜1 曾海鸥1 罗敏虹1 袁丽萍1 马红梅1 伍强1 李强翔2 杨铁城1*
(1广东省深圳市第四人民医院肾内科,深圳市518000;2湖南省中医药大学中西结合博士后流动站,长沙市410208)
Author(s):
CHEN Zhen-wei1 ZENG Hai-ou1 LUO Min-hong1 YUAN Li-ping1 MA Hong-mei1 WU Qiang1 LI Qiang-xiang2 YANG Tie-cheng1
(1Department of Nephrology, the Fourth People′s Hospital of Shenzhen, Shenzhen 518000, China; 2 Post-doctoral research station, Hunan University of Traditional Chinese Medicine, changsha 410208, China)
关键词:
糖尿病肾病血液透析钙化危险因素
Keywords:
Diabetic nephropathy Hemodialysis Calcification Risk factors
分类号:
R 692.3
DOI:
DOI:10.16121/j.cnki.cn45-1347/r.2015.05.02
文献标志码:
A
摘要:
目的探讨糖尿病肾病(DN)与非糖尿肾病(NDN)维持性血液透析(MHD)患者桡动脉钙化(RAC)情况及其危险因素。方法选择维持性血液透析患者104例作为研究对象,其中DN患者30例(DN组),NDN患者74例(NDN组),比较分析两组患者一般情况、生化指标及RAC等的差异,探讨DN、NDN患者RAC情况及其危险因素。结果104例MHD患者中发生RAC 20例,发生率为19.2%,DN组患者钙化发生率为46.7%(14/30),NDN组患者钙化发生率为8.1%(6/74)。DN组患者年龄、血肌酐、血管钙化情况与NDN组患者比较,差异有统计学意义(P<0.05)。多元线性逐步回归分析结果显示,糖尿病、中位透析龄≥60个月是MHD患者发生RAC的相对危险因素。结论在MHD患者中,DN患者的RAC发生率显著高于NDN患者,糖尿病、透析时间≥60个月是MHD患者发生RAC的相对危险因素。
Abstract:
ObjectiveTo explore radial artery calcification(RAC) and its risk factors in maintenance hemodialysis (MHD) patients with and without diabetic nephropathy. MethodsA total of 104 MHD patients were enrolled including 30 cases of DN (DN group) and 74 cases of non-DN(NDN group). General situation, biochemical parameters and RAC between the two groups were compared. Risk factors relating to RAC in the two groups were also explored. ResultsOf all the 104 MHD cases, there were 20 cases with RAC(19.2%). The incidences of RAC in DN group and NDN group were 46.7%(14/30) and 8.1%(6/74), respectively. There were significant differences in age, serum creatinine, and RAC between two groups (P<0.05). Multiple linear stepwise regression analysis indicated that diabetics and duration of dialysis≥60 months are the relative risk factors of RAC occurrence. ConclusionsThe MHD patients with DN have higher prevalence rate of RAC than those without DN. Diabetics and duration of dialysis≥60 months were the relative risk factors of RAC.

参考文献/References:

[1]Shaw JE,Sicree RA,Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030[J].Diabetes Res Clin Pract,2010,87(1):4-14.
[2]Giachelli CM.Vascular calcification mechanisms[J].J Am Soc Nephrol,2004,15(12):2959-2964.
[3]Hernandez D,Rufino M,Bartolomei S,et al.Clinical impact of preexistingvascular calcifications on mortality after renal transplantation[J].Kidney Int,2005,67(5):2015-2020.
[4]Moe SM,Chen NX. Pathophysiology of vascular calcification in chronic kidney disease[J].Circ Res,2004,95(6):560-567.
[5]Hernandez D,Rufino M,Bartolomei S,et al.Clinical impact of preexistingvascular calcifications on mortality after renal transplantation[J].Kidney Int,2005,67(5):2015-2020.
[6]Ventura JE,Tavella N,Romero C,et al.Aortic valve calcification is an independent factor of left ventricular hypertrophy in patients on maintenancehaemodialysis[J].Nephrol Dial Transplant,2002,17(10):1795-1801.
[7]Kalpakian MA,Mehrotra R. Vascular calcification and disordered mineral metabolism in dialysis patients[J].Semin Dial,2007,20(2):139-143.
[8]Liu ZH, China Dialysis Calcification Study (CDCS) Group.Vascular calcification burden of Chinese patients with chronic kidney disease: methodology of a cohort study[J].BMC Nephrol,2015,16:129.
 [9]Garland JS,Holden RM,Groome PA,et al. Prevalence and associations of coronary artery calcification in patients with stages 3 to 5 CKD without cardiovascular disease[J].Am J Kidney Dis,2008,52(5):849-858.
[10]Adeney KL,Siscovick DS,Ix JH,et al.Association of serum phosphate with vascular and valvular calcification in moderate CKD[J].J Am Soc Nephrol,2009,20(2):381-387.
[11]Raggi P,Bellasi A,Ferramosca E,et al.Association of pulse wave velocity with vascular and valvular calcification in hemodialysis patients[J].Kidney Int,2007,71(8):802-807.
[12]Ishimura E,Okuno S,Taniwaki H,et al.Different risk factors forvascular calcification in end-stage renal disease between diabetics and nondiabetics: the respective importance of glycemic and phosphate control[J].Kidney Blood Press Res,2008,31(1):10-15.
[13]Racki S,Zaputovi L,Vujici B,et al.Comparison of survival between diabetic and non-diabetic patients on maintenance hemodialysis:a single-centre experience[J].Diabetes Res Clin Pract,2007,75(2):169-175.
[14]Russo D,Palmiero G,De Blasio AP,et al.Coronary artery calcification in patients with CRF not undergoing dialysis[J]. Am J Kidney Dis,2004,44(6):1024-1030.
[15]Kramer H,Toto R,Peshock R,et al. Association between chronic kidney disease and coronary artery calcification: the Dallas Heart Study[J]. J Am Soc Nephrol,2005,16(2):507-513.
[16]Inoue T,Ogawa T,Ishida H,et al.Aortic arch calcification evaluated on chest X-ray is a strong independent predictor of cardiovascular events in chronic hemodialysis patients[J].Heart Vessels,2012,27(2):135-142.
[17]Goodman WG,Goldin J,Kuizon BD,et al.Coronary artery calcification in young adults with end-stage renal disease who are undergoing dialysis[J].N Engl J Med,2000,342(20):1478-1483.

相似文献/References:

[1]宋效成 李赐林 黄斌* 周凤梁.前列地尔联合α硫辛酸治疗早期糖尿病肾病疗效观察[J].内科,2015,(02):150.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2015.02.04]
 SONG Xiao-cheng,LI Ci-lin,HUANG Bin*,et al.Observation on alprostadil combined with alpha-lipoic acid in treatment of early diabetic nephropathy[J].Internal Medicine of China,2015,(05):150.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2015.02.04]
[2]邱海薇 缪丽春.糖尿病肾病腹膜透析患者的焦虑抑郁状况分析[J].内科,2015,(02):212.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2015.02.29]
 [J].Internal Medicine of China,2015,(05):212.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2015.02.29]
[3]彭云波 覃永旗 王权明.血清同型半胱氨酸检测在糖尿病肾病早期诊断价值[J].内科,2014,(06):663.
 [J].Internal Medicine of China,2014,(05):663.
[4]罗浩 廖家贤 莫隽 罗梅 张勤波.超声引导下右颈内静脉穿刺置管在血液透析中的应用[J].内科,2013,(01):13.
 LUO Hao,LIAO Jia-xian,MO Jun,et al.The clinical application of ultrasound in right internal jugular vein catheterization during hemodialysis[J].Internal Medicine of China,2013,(05):13.
[5]黄永芳.动脉穿刺技巧在血透中的应用探讨[J].内科,2013,(01):51.
 [J].Internal Medicine of China,2013,(05):51.
[6]墨玺霞 黎蠡.控制血液透析患者干体重对其心功能影响的临床观察[J].内科,2013,(02):138.
 [J].Internal Medicine of China,2013,(05):138.
[7]梁建丽(广西灵山县人民医院血透室,灵山县00).维持性血液透析患者生活质量测评及影响因素研究现状[J].内科,2013,(02):191.
 [J].Internal Medicine of China,2013,(05):191.
[8]吕干.川芎嗪联合贝那普利治疗糖尿病肾病的疗效分析[J].内科,2013,(03):256.
 [J].Internal Medicine of China,2013,(05):256.
[9]陆桢.糖尿病肾病药物治疗进展[J].内科,2013,(04):415.
 [J].Internal Medicine of China,2013,(05):415.
[10]李月娥.血液透析中常见的护理风险与护理对策[J].内科,2013,(05):516.
 [J].Internal Medicine of China,2013,(05):516.

备注/Memo

备注/Memo:
(收稿日期:2015-06-14修回日期:2015-08-11)
基金项目:中国博士后科学基金第53批面上资助(2013M531788);深圳市福田区卫生公益性科研项目(FTWS201312)
 *通讯作者
更新日期/Last Update: 2015-10-28